Committed to sharing our science

Committed to sharing our science

327 results available

Cytochrome P450 (CYP) Phenotyping of Aficamten, a Next-in-class Inhibitor of Cardiac Myosin, Using Human Liver Microsomes and Human Recombinant CYP Enzymes

Poster, ISSX/JSSX 2024

Sukhun, R et al

September 15, 2024
Qualitative Interview Study of Patient-reported Symptoms, Impacts and Treatment Goals of Patients With Obstructive Hypertrophic Cardiomyopathy

BMJ Open

Shore, S et al

September 17, 2024
Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data

American Journal of Cardiovascular Drugs

Butzner M, et al

August 22, 2024
Pharmacokinetics, Disposition, and Biotransformation of the Cardiac Myosin Inhibitor Aficamten in Humans

Pharmacology Research & Perspectives

Xu, D et al

September 10, 2024
Menopausal Status and Clinical Outcomes in Women with Heart Failure with Reduced Ejection Fraction: the GALACTIC-HF Trial

Poster, ESC 2024

Pabon, MA et al

September 2, 2024